The "Elevate" by MAPS Podcast

The role of real-world evidence (RWE) in Medical Affairs has greatly evolved in the last few years. The clinical evidence regarding the potential benefits or risks of a therapy generated from data relating to patient health or the delivery of health care can add value at every stage of a product’s lifecycle. RWE can not only help support a product’s safe and appropriate use in a post-approval setting, but the data can also inform innovation, trial design, personalized medicine, regulatory filings and optimize decision-making for better patient outcomes. In this episode, we hear from RWE and industry experts on the importance of early alignment of your evidence generation plan and medical strategy and how to integrate RWE into your publication plan.

Conference prep requires more than placing publications, securing booth space and scheduling as many KOL meetings as possible. Here we speak with Chris Medieros, Director of Strategic Insights, H1, about how to maximize your organization's presence and impact at congresses, including how to plan strategically across the workflow of KOL interactions.

In today's episode of the MAPS "Elevate" podcast, we'll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy and reviewing the following questions:

1. How do you the see the role of Medical Affairs evolving in the era of advance therapeutics like gene therapy, often investigated for rare disorders? Are there specialized skillsets MA professionals need to be successful in this area? 
2. What are three major differences in approach to Med Affairs planning in rare disease, whether or not there is a gene therapy involved? 
3. From your experience, what are the biggest hurdles for Med Affairs professionals educating HCPs on gene therapy? It sounds really exciting in concept, but does the reality differ in practice? 
4. What advice is there for Med Affairs colleagues wanting to work in either rare disease or gene therapy? Are there specialized roles coming up in this space, different from current roles?

This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives. External Education of a growing variety of stakeholders in healthcare by the Medical Affairs Division of Pharma and Medical Device industry reflects the critical role Education in Medicine plays in our Age of Information. The podcast features critical discussions with leading educators across healthcare from the various perspectives of pharma / biotech sponsors, program organizers, attendees, and patients with a quest to explore some of the most novel, intriguing formats of Medical Education, following their approaches to learning in our digital age as well as their current gaps or success stories. The goal of the podcast is to make medical education simpler to access, more relevant to apply across healthcare organizations, and more continuous to inspire innovation and quality.

This second episode in the series discusses the activities of the External Education FAWG and the different learning opportunities that are currently available and coming soon to all MAPS members. Our host, Tim Mikhelashvili, PharmD, Co-Founder and CEO of Amedea Pharma and Chair of the Mentorship Program at the Medical Affairs Professional Society (MAPS) speaks with Sarah Funderburk, SVP Senior Medical Strategy Director with Caudex and Partner Circle member of the External Education FAWG. Sarah discusses some of her learnings from the area of company-led education and her vision for where emerging technologies could take medical education in the future. She addresses the gaps in personalizing education for healthcare consumers and providers based on Salesforce’s latest global Connected Health Consumer Report, and reviews the role of programs such as ChatGPT, Tome, and Synesthesia on medical education. Listen to the episode to hear how, when and where you can take advantage of the many exciting activities being offered by the External Education FAWG.

In this episode of the Elevate podcast series, MAPS speaks with experts from Altmetric about tackling the challenges of an expanding world and understanding who is communicating research by measuring Share of Voice. 

This episode is sponsored by Altmetric. 

• How and why medical publishing is changing and where is it going in the future.
• The benefits of digital-first development of manuscripts.
• How enhanced content can improve publication access and resonance.

MAPS speaks with Tim Mikelhashvili and winners of his Medical Affairs Innovation Olympics about applications that can match patients with clinical trials and provide real-time input to provide context for clinical decisions.

When we think about Medical Insights, the first function that comes to mind is Field Medical and capturing/analyzing MSL/HCP interactions in ways that lead to strategic actions. But there are other sources of insights, including the Medical Information function. Many organizations are already capturing and quantifying MedInfo requests to learn more about the types of questions HCPs are asking. Now tools exist to look deeper into this data, allowing MedInfo teams to truly contribute to the generation, analysis of Medical Insights. Learn more in this episode of the MAPS podcast series, Elevate.

On today's episode, we're Speaking with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, and the winners of his Medical Affairs Olympics Competition who dared to come together to share ideas across MA functions.

This podcast is sponsored by Amedea Pharma.

This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives. External Education of a growing variety of stakeholders in healthcare by the Medical Affairs Division of Pharma and Medical Device industry reflects the critical role Education in Medicine plays in our Age of Information. The podcast features critical discussions with leading educators across healthcare from the various perspectives of pharma / biotech sponsors, program organizers, attendees, and patients with a quest to explore some of the most novel, intriguing formats of Medical Education, following their approaches to learning in our digital age as well as their current gaps or success stories. The goal of the podcast is to make medical education simpler to access, more relevant to apply across healthcare organizations, and more continuous to inspire innovation and quality.

This is a first of a series of episodes that examines the podcast as one of the most effective emerging channels and formats of education in medicine. Our host, Tim Mikhelashvili, PharmD, Co-Founder and CEO of Amedea Pharma and Chair of the Mentorship Program at the Medical Affairs Professional Society (MAPS) speaks with Shelby Englert, Vice President of Education at the American Urological Association to learn why podcasts are powerful from a Professional Medical Society’s perspective. Shelby explains why its organization started its AUA University podcast, now with 165 episodes and the role it has played in building and growing its community of urologists in the association. She also describes how the AUA University podcast is structured, how it has evolved over time, and shares personal suggestions for elements of education most valuable and relevant to an audience in a podcast, providing specific examples that demonstrate the direct impact of the podcast on patient and physician behaviors as well as health outcomes. Listen to this episode because it not only centers on the ultimate impact of podcasts on the quality of medical education, but also discusses all the “supporting players” and “accessories” to the podcast required such as channels, technology, and timing of podcast communication to make a podcast successful and valuable in healthcare.